Evaluation of dementia-preventing effect of multitasking exercise by beta amyloid : 18-month randomized trial

Evaluation of dementia-preventing effect of multitasking exercise by beta amyloid : 18-month randomized trial - Evaluation of dementia prevention effect of multitasking exercise by beta amyloid

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000050240

Enrollment

224

Registered

2023-05-01

Start date

2021-12-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy subjects

Interventions

Square-stepping exercise Walking Control

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1) A person who participated in the blood sampling test conducted by Kasama City in 2019 2) A person who is not prohibited from exercising by their doctor 3) A person who can go to the place where the experiment is conducted on their own

Exclusion criteria

Exclusion criteria: 1) A person with dementia 2) A person with paralysis 3) A person who has an allergic reaction to the ingredients of the test food 4) A person who is currently participating in other clinical studies or who have participated within 3 months 5) A person who is judged by the principal investigator to be inappropriate as the subjects of this study

Design outcomes

Primary

Measure	Time frame
Composite biomarker (Beta amyloid 1-40, beta amyloid 1-42, beta amyloid protein precursor 669-711)	—

Secondary

Measure	Time frame
cognitive function Physical function Physical activity Mental health	—

Countries

Japan

Contacts

Public ContactYOON Jieun

University of Tsukuba R&D Center for Tailor-Made QOL

yoon.jieunfu@u.tsukuba.ac.jp+81-029-839-1593

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026